Parkinson's Disease
Conference Coverage
Global burden of brain disorders surpasses cardiovascular disease and cancer
“The burden of brain conditions will increase as populations continue to grow and age.”
Latest News
Smartwatches able to detect very early signs of Parkinson’s
With these results we could develop a valuable screening tool to aid in the early detection of Parkinson's," one of the investigators said.
Literature Review
Can a repurposed Parkinson’s drug slow ALS progression?
One expert interviewed for this article said the study “falls short of being a credible 1/2a clinical trial.”
From the Journals
Gout linked to smaller brain volume, higher likelihood of neurodegenerative diseases
Patients with gout may have smaller brains with more iron, and they may be at increased risk for developing dementia and other neurodegenerative...
Latest News
Potential new treatment for REM sleep behavior disorder
The disorder can signal risk for synucleinopathies, a group of neurological conditions such as Parkinson's disease that involve the formation of...
Literature Review
‘Robust evidence’ that exercise cuts Parkinson’s risk in women
“These results show that the field is moving in the right direction and provide a clear rationale for exercise trials to prevent or delay the...
Literature Review
Parkinson’s in Marines linked to toxic drinking water at Camp Lejeune
“This is by far the largest study to look at the association of TCE and PD and the evidence is pretty strong.”
Literature Review
Common gut bacteria linked to Parkinson’s disease
The findings highlight the potential for screening and targeted removal of harmful Desulfovibrio bacteria.
From the Journals
Rheumatoid arthritis linked to increased Parkinson’s risk
“If patients with rheumatoid arthritis begin exhibiting motor symptoms such as muscle rigidity, tremors, or slowed movement, it is imperative that...
Conference Coverage
Novel levodopa delivery system promises continuous dosing without surgery or pump
The experimental device is designed to deliver levodopa and carbidopa into the mouth through a micropump within a wearable retainer.
Conference Coverage
Phase 3 study of new levodopa/carbidopa delivery system meets all efficacy endpoints
The subcutaneous infusion system improved ON time without troublesome dyskinesias while improving symptoms according to ratings from both patients...